Molecular Stethoscope: Gajus Worthington

Molecular Stethoscope has appointed Gajus Worthington as executive chairman of its board of directors. Worthington has been chief operating officer of the Chan Zuckerberg Biohub since May of 2017, where he has worked with leadership to set strategy, build, and oversee much of the organization. Prior to that, he served as CEO of Fluidigm, where, during a 17-year tenure, he led the development and commercialization of that company's microfluidics technology, with applications in single-cell genomics, agriculture, and diagnostic testing. Worthington holds a bachelor's degree in physics and a master's degree in electrical engineering from Stanford University. He is an elected fellow of the American Institute for Medical and Biological Engineering.